J&J | JNJ - Debt


J&J reported $54.99B in Debt for its fiscal quarter ending in March of 2026.





Debt Change Date
AbbVie USD 72.86B 5.36B Mar/2026
Abbott USD 34.05B 20.19B Mar/2026
Amgen USD 57.32B 2.72B Mar/2026
AstraZeneca USD 32.24B 1.68B Jun/2026
Baxter International USD 9.69B 93M Mar/2026
Bayer EUR 36.45B 2.93B Dec/2025
Becton, Dickinson and Co. USD 17.28B 2.26B Mar/2026
Biogen USD 8.09B 1.53B Jun/2026
Boston Scientific USD 11.03B 407M Mar/2026
Bristol-Myers Squibb USD 46.43B 711M Mar/2026
CONMED USD 860.87M 25.93M Mar/2026
Cooper Companies USD 2.5B 5.6M Dec/2025
Dexcom USD 1.24B 900K Mar/2026
Edwards Lifesciences USD 600M 105.4M Mar/2026
Eli Lilly USD 43.37B 867M Mar/2026
Gilead Sciences USD 22.17B 2.76B Mar/2026
GlaxoSmithKline GBP 19.06B 1.34B Mar/2026
Globus Medical USD 115.22M 3.43M Mar/2026
Insulet USD 948.4M 300K Jun/2026
Integra LifeSciences USD 2.04B 6.27M Mar/2026
Intuitive Surgical USD 0 0 Mar/2025
J&J USD 54.99B 7.05B Mar/2026
Medtronic USD 28.07B 1.03B Dec/2025
Merck USD 49.12B 222M Mar/2026
Merit Medical Systems USD 821.56M 9K Mar/2026
Novartis USD 49.01B 2.02B Jun/2026
Pfizer USD 63.73B 231M Mar/2026
Regeneron Pharmaceuticals USD 2.71B 400K Jun/2026
Roche Holding CHF 33.03B 1.41B Jun/2025
Sanofi EUR 23.58B 3.56B Jun/2026
Stryker USD 14.19B 32M Jun/2026
Tandem Diabetes Care USD 602.58M 132.16M Jun/2026
Teva Pharmaceutical Industries USD 16.91B 187M Mar/2026
Vertex Pharmaceuticals USD 1.99B 44M Mar/2026
Zimmer Biomet Holdings USD 7.48B 8M Jun/2026
Zoetis USD 9.24B 0 Mar/2026